Patents by Inventor Pragnya Das

Pragnya Das has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230097886
    Abstract: The present invention includes a composition and method for preventing at least one of: neonatal lung injury, bronchopulmonary dysplasia (BPD), or BPD-associated pulmonary hypertension (BPD-PH) comprising: a compound of formula (I) and variants thereof: in an amount sufficient to prevent at least one of: neonatal lung injury, bronchopulmonary dysplasia (BPD), or BPD-associated pulmonary hypertension (BPD-PH).
    Type: Application
    Filed: July 26, 2022
    Publication date: March 30, 2023
    Inventors: Suchismita Acharya, Pragnya Das
  • Patent number: 11364253
    Abstract: The present invention includes novel compositions and methods for treating comprising a compound with the Formula I: where n=0-5; X?NH, O, S, CH2; Y=Phenyl, a phenyl group substituted with at least one methyl, a phenyl group substituted with at least one nitro, a phenyl group substituted with at least one nitrogen, a phenyl group substituted with at least one boron, aryl, substituted aryl, heteroaryl, four to six membered cycloalkyl, four to six membered heterocycloalkyl; R?H, C(O)R2, SO2R2; R1?H, C(O)R2, SO2R2; R2=Ethyl, methyl, isopropyl, n-propyl, t-butyl, n-butyl, NH2, NR3R4, R3, R4=Ethyl, methyl, isopropyl, n-propyl, t-butyl, n-butyl, three to six membered cycloalkyl and Z?NH, O, S, CH2 or none, wherein the amount of the compound is selected to either inhibit or activate the immune response.
    Type: Grant
    Filed: July 2, 2019
    Date of Patent: June 21, 2022
    Assignee: AYUVIS RESEARCH, INC.
    Inventors: Suchismita Acharya, Pragnya Das, Beamon Agarwal
  • Patent number: 11207343
    Abstract: The present invention is directed to novel products, variants, pharmaceutically acceptable salts and prodrugs thereof, and medical use of such compounds for the treatment and/or management of sepsis, septicemia, septic shock, ocular infection, ocular inflammation, ocular angiogenesis, rheumatoid arthritis (RA), atherosclerosis, inflammatory bowel diseases (IBD), asthma, chronic obstructive pulmonary disease, fever syndromes, cachexia, psoriasis, autoimmune diseases, cardiac diseases, retinoblastoma, cancer and/or any disorder associated with inflammation, immunomodulation and microbial infection.
    Type: Grant
    Filed: March 30, 2017
    Date of Patent: December 28, 2021
    Assignee: AYUVIS RESEARCH, INC.
    Inventors: Suchismita Acharya, Santosh K Panda, Pragnya Das, Beamon Agarwal
  • Publication number: 20200022995
    Abstract: The present invention includes novel compositions and methods for treating comprising a compound with the Formula I: where n=0-5; X=NH, O, S, CH2; Y=Phenyl, a phenyl group substituted with at least one methyl, a phenyl group substituted with at least one nitro, a phenyl group substituted with at least one nitrogen, a phenyl group substituted with at least one boron, aryl, substituted aryl, heteroaryl, four to six membered cycloalkyl, four to six membered heterocycloalkyl; R?H, C(O)R2, SO2R2; R1=H, C(O)R2, SO2R2; R2=Ethyl, methyl, isopropyl, n-propyl, t-butyl, n-butyl, NH2, NR3R4, R3, R4 =Ethyl, methyl, isopropyl, n-propyl, t-butyl, n-butyl, three to six membered cycloalkyl and Z=NH, O, S, CH2 or none, wherein the amount of the compound is selected to either inhibit or activate the immune response.
    Type: Application
    Filed: July 2, 2019
    Publication date: January 23, 2020
    Inventors: Suchismita Acharya, Pragnya Das, Beamon Agarwal
  • Publication number: 20170281667
    Abstract: The present invention is directed to novel products, variants, pharmaceutically acceptable salts and prodrugs thereof, and medical use of such compounds for the treatment and/or management of sepsis, septicemia, septic shock, ocular infection, ocular inflammation, ocular angiogenesis, rheumatoid arthritis (RA), atherosclerosis, inflammatory bowel diseases (IBD), asthma, chronic obstructive pulmonary disease, fever syndromes, cachexia, psoriasis, autoimmune diseases, cardiac diseases, retinoblastoma, cancer and/or any disorder associated with inflammation, immunomodulation and microbial infection.
    Type: Application
    Filed: March 30, 2017
    Publication date: October 5, 2017
    Inventors: Suchismita Acharya, Santosh K. Panda, Pragnya Das, Beamon Agarwal